芯原股份(688521.SH):集成了芯原神經網絡處理器IP的人工智能類芯片已在全球範圍內出貨超過1億顆
格隆匯12月31日丨芯原股份(688521.SH)在互動平台表示,公司在嵌入式AI/NPU領域全球領先,芯原的神經網絡處理器(NPU)IP已被72家客户用於上述市場領域的128款AI芯片中,集成了芯原神經網絡處理器IP的人工智能(AI)類芯片已在全球範圍內出貨超過1億顆,主要應用於物聯網、可穿戴設備、智慧電視、智慧家居、安防監控、服務器、汽車電子、智能手機、平板電腦、智慧醫療等10個市場領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.